MAUREEN POE: Open Payments
NPI 1992700272 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 28 payments from 12 companies in 2025. Trend: 2023 $1,356 · 2024 $916 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $308 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $112 |
| ABBVIE INC. | 3 | $87 |
| Exact Sciences Corporation | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
Products named: AIRSUPRA, Auvelity, IBSRELA, XIFAXAN, BREZTRI, QULIPTA, The Cologuard Plus Collection Kit, CAPLYTA.
Industry payments across LA — which companies pay providers there.
